16 September 2021 | News
Significantly extended capabilities in biological drug discovery, process development, testing and validation to meeting growing local customer demand
image credit- twitter
Sartorius has officially opened its new, significantly expanded Application and Service Hub in Zhangjiang Science City in Shanghai, China.
Equipped with the latest innovative instrumentation and offering cutting-edge professional expertise, this Hub covering over 3,000 square meters accommodates the Sartorius Application Center 3.0, the Confidence® Validation Services Laboratory 2.0 and APAC Service Hub.
This combined facility is designed as an integrated solution platform to empower and accelerate progress in areas ranging from research to process development to production in the Chinese life sciences and biopharmaceutical industries.
The latest innovations in bioanalytic, continuous processing and digitalization are now going live in the upgraded Application Center 3.0, where the new Sartorius process solutions will be showcased and experienced as their first point of entry.
More importantly, early stage monoclonal antibody (mAb) and virus-based therapies can be discovered, and their process applications can be custom developed, tested, and verified.
Also, the Sartorius Laboratory and Service Center in YETDA Biopark in Yantai, China, is under construction. As of the first half of 2022, this facility will provide timely, on-site support to our customers and biotech startups in their drug discovery and early development phases. Sartorius currently employs more than 700 team members in China and is continuously expanding its local organization.